Head-to-head · WeighScore
AmberHealth vs Candor Rx
By GLP-1 ScorecardUpdated
Score comparison
AmberHealth has the higher recorded score — 82.9/100 to 74.8/100.
AmberHealth grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Round-$100 semaglutide nationwide, though tirzepatide runs $175 and it isn't verified.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | AmberHealth | Candor Rx |
|---|---|---|
| WeighScore | 82.9/100 | 74.8/100 |
| Grade | B− | C |
| Site position | #24 | #62 |
| Semaglutide | $100/mo | $99/mo (all doses, compounded) |
| Tirzepatide | $175/mo | $149/mo (all doses, compounded) |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #24 · B−
Strengths
- $100 semaglutide
- All 50 states
- Both molecules
What to consider
- Independent LegitScript certification has not been verified for this review
- Tirzepatide $175
- Monitoring detail sparse
Site position #62 · C
Strengths
- Flat, dose-independent pricing marketed as '$95/month, any dose, forever' — no upcharge as your dose increases
- Low starting prices: compounded semaglutide as low as $99/mo and tirzepatide as low as $149/mo
- Medication ships in about 48 hours and you can cancel anytime
- Simple, transparent GLP-1 focus with pricing shown up front before signup
What to consider
- Prescribing medical group and compounding pharmacy are not named on the site
- States of operation are not published; confirm eligibility during intake
- No LegitScript certification is displayed
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.